Bone morphogenetic protein receptors

Bone

Volumn 19, Issue 6, 1996, Pages 569-574

  Yamashita, H ^a,b   Ten Dijke, P ^c   Heldin, C H ^c   Miyazono, Kohei ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER INSTITUTE   (Japan)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; PROTEIN SERINE THREONINE KINASE; RECEPTOR;

EMBRYO DEVELOPMENT; LIGAND BINDING; MORPHOGENESIS; RECEPTOR BINDING; REVIEW;

ANIMALS; BINDING SITES; BONE AND BONES; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; EMBRYONIC AND FETAL DEVELOPMENT; HUMANS; LIGANDS; MORPHOGENESIS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; SECOND MESSENGER SYSTEMS;

EID: 0030461022     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(96)00259-1     Document Type: Review

References (52)

1. 1. Arora, K., Dai, H., Kazuko, S. G., Jamal, J., O'Connor, M. B., Letsou, A., and Warrior, R. The Drosophila schnurri gene acts in the Dpp/TGFβ signaling pathway and encodes a transcription factor homologous to the human MBP family. Cell 81:781-790; 1995.
2. 2. Attisano, L., Wrana, J. L., Cheifetz, S., and Massagué, J. Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68:97-108; 1992.
3. 3. Cárcamo, J., Weis, F. M. B., Ventura, F., Wieser, R., Wrana, J. L., Attisano, L., and Massagué, J. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol Cell Biol 14:3810-3821; 1994.
4. 4. Cárcamo, J., Zentella, A., and Massagué, J. Disruption of transforming growth factor β signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol Cell Biol 15:1573-1581; 1995.
5. 5. Dewulf, N., Verschueren, K., Lonnoy, O., Morén, A., Grimsby, S., Vande Spiegle, K., Miyazono, K., Huylebroeck, D., and ten Dijke, P. Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology 136:2652-2663; 1995.
6. 6. Dudley, A. T., Lyons, K. M., and Robertson, E. J. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9:2795-2807; 1995.
7. 7. Estevez, M., Attisano, L., Wrana, J. L., Albert, P. S., Massagué, J., and Riddle, D. L. The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development. Nature 365:644-649; 1993.
8. 8. Franzén, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C.-H., and Miyazono, K. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 75:681-692; 1993.
9. 9. Georgi, L. L., Albert, P. S., and Riddle, D. L. daf-1, a C. elegans gene controlling dauer larva development, encodes a novel receptor protein kinase. Cell 61:635-645; 1990.
10. 10. Graff, J. M., Bansal, A., and Melton, D. A. Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell 85:479-487; 1996.
11. 11. Graff, J. M., Thies, R. S., Song, J. J., Celeste, A. J., and Melton, D. A. Studies with a Xenopus BMP receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo. Cell 79:169-179; 1994.
12. 12. Grieder, N. C., Nellen, D., Burke, R., Basler, K., and Affolter, M. schnurri is required for Drosophila Dpp signaling and encodes a zinc finger protein similar to the mammalian transcription factor PRDII-BF1. Cell 81:791-800; 1995.
13. 13. Hahn, S. A., Schutte, M., Hoque, A. T. M. S., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353; 1996.
14. 14. Hoodless, P. A., Haerry, T., Abdollah, S., Stapleton, M., O'Connor, M. B., Attisano, L., and Wrana, J. L. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85:489-500; 1996.
15. 15. Ishidou, Y., Kitajima, I., Obama, H., Maruyama, I., Murata, F., Imamura, T., Yamada, N., ten Dijke, P., Miyazono, K., and Sakou, T. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. J Bone Miner Res 10:1651-1659; 1995.
16. 16. Ishikawa, T., Yoshioka, H., Ohuchi, H., Noji, S., and Nohno, T. Truncated type II receptor for BMP-4 induces secondary axial structures in Xenopus embryos. Biochem Biophys Res Commun 216:26-33; 1995.
17. 17. Kawabata, M., Chytil, A., and Moses, H. L. Cloning of a novel type II serine/ threonine kinase receptor through interaction with the type I transforming growth factor-β receptor. J Biol Chem 270:5625-5630; 1995.
18. 18. Kawabata, M., Imamura, T., Miyazono, K., Engel, M. E., and Moses, H. L. Interaction of the transforming growth factor-β type I receptor with farnesyl-protein transferase-α. J Biol Chem 270:29628-29631; 1995.
19. 19. Kingsley, D. M., Bland, A. E., Grubber, J. M., Marker, P. C., Russell, L. B., Copeland, N. G., and Jenkins, N. A. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGFβ superfamily. Cell 71:399-410; 1992.
20. 20. Koenig, B. B., Cook, J. S., Wolsing, D. H., Ting, J., Tiesman, J. P., Correa, P. E., Olson, C. A., Pecquet, A. L., Ventura, F., Grant, R. A., Chen, G.-X., Wrana, J. L., Massagué, J., and Rosenbaum, J. S. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol Cell Biol 14:5961-5974; 1994.
21. 21. Lechleider, R. J., de Caestecker, M. P., Dehejia, A., Polymeropoulos, M. H., and Roberts, A. B. Serine phosphorylation, chromosomal localization and TGF-β signal transduction by human bsp-1. J Biol Chem 271:17617-17620; 1996.
22. 22. Letsou, A., Arora, K., Wrana, J. L., Simin, K., Twombly, V., Jamal, J., Stahling-Hampton, K., Hoffmann, F. M., Gelbart, W. M., Massagué, J., and O'Connor, M. B. Drosophila Dpp signaling is mediated by the punt gene product: A dual ligand-binding type II receptor of the TGFβ receptor family. Cell 80:899-908; 1995.
23. 23. Lin, H. Y., Wang, X.-F., Ng-Eaton, E., Weinberg, R. A., and Lodish, H. F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785; 1992.
24. 24. Liu, F., Hata, A., Baker, J. C., Doody, J., Cárcamo, J., Harland, R. M., and Massagué, J. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381:620-623; 1996.
25. 25. Liu, F., Ventura, F., Doody, J., and Massagué, J. Human type II receptor for bone morphogenic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 15:3479-3486; 1995.
26. 26. Luo, G., Hofmann, C., Bronckers, A. L. J. J., Sohocki, M., Bradley, A., and Karsenty, G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9:2808-2820; 1995.
27. 27. Mathews, L. S. and Vale, W. W. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65:973-982; 1991.
28. 28. Matzuk, M. M., Kumar, T. R., and Bradley, A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 374:356-360; 1995.
29. 29. Mishina, Y., Suzuki, A., Ueno, N., and Behringer, R. R. Bmprencodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 9:3027-3037; 1995.
30. 30. Moriguchi, T., Kuroyanagi, N., Yamaguchi, K., Gotoh, Y., Irie, K., Kano, T., Shirakabe, K., Muro, Y., Shibuya, H., Matsumoto, K., Nishida, E., and Hagiwara, M. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J Biol Chem 271:13675-13679; 1996.
31. 31. Nishiotoh, H., Ichijo, H., Kimura, M., Matsumoto, T., Makishima, F., Yamaguchi, A., Yamashita, H., Enomoto, S., and Miyazono, K. Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem 271:21345-21352; 1996.
32. 32. Nohno, T., Ishikawa, T., Saito, T., Hosokawa, K., Noji, S., Wolsing, D. H., and Rosenbaum, J. S. Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J Biol Chem 270:22522-22526; 1995.
33. 33. Reddi, A. H. Bone and cartilage differentiation. Curr Opin Genet Develop 4:737-744; 1994.
34. 34. Rosenzweig, B. L., Imamura, T., Okadome, T., Cox, G. N., Yamashita, H., ten Dijke, P., Heldin, C.-H., and Miyazono, K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92:7632-7636; 1995.
35. 35. Ruberte, E., Marty, T., Nellen, D., Affolter, M., and Basler, K. An absolute requirement for both the type II and type I receptors, Punt and Thick veins, for Dpp signaling in vivo. Cell 80:889-897; 1995.
36. 36. Sekelsky, J. J., Newfeld, S. J., Raftery, L. A., Chartoff, E. H., and Gelbart, W. M. Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139:1347-1358; 1995.
37. 37. Shibuya, H., Yamaguchi, K., Shirakabe, K., Tonegawa, A., Gotoh, Y., Ueno, N., Irie, K., Nishida, E., and Matsumoto, K. TAB1: An activator of the TAK1 MAPKKK in TGF-β signal transduction. Science 272:1179-1182.
38. 38. Storm, E. E., Huynh, T. V., Copeland, N. G., Jenkins, N. A., Kingsley, D. M., and Lee, S.-J. Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily. Nature 368:639-643; 1994.
39. 39. Suzuki, A., Thies, R. S., Yamaji, N., Song, J. J., Wozney, J. M., Murakami, K., and Ueno, N. A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo. Proc Natl Acad Sci USA 91:10255-10259; 1994.
40. 40. ten Dijke, P., Miyazono, K., and Heldin, C.-H. Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr Opin Cell Biol 8:139-145; 1996.
41. 41. ten Dijke, P., Yamashita, H., Ichijo, H., Franzén, P., Laiho, M., Miyazono, K., and Heldin, C.-H. Characterization of type I receptors for transforming growth factor-β and activin. Science 265:101-104; 1994.
42. 42. ten Dijke, P., Yamashita, H., Sampath, T. K., Reddi, A. H., Estevez, M., Riddle, D. L., Ichijo, H., Heldin, C.-H., and Miyazono, K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 269:16985-16988; 1994.
43. 43. Thomas, J. T., Lin, K., Nandedkar, M., Camargo, M., Cervenka, J., and Luyten, F. P. A human chondrodysplasia due to a mutation in a TGF-β superfamily member. Nature Genet 12:315-317; 1996.
44. 44. Weis-Garcia, F. and Massagué, J. Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperatively essential for signaling. EMBO J 15:276-289; 1996.
45. 45. Wieser, R., Wrana, J. L., and Massagué, J. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J 14:2199-2208; 1995.
46. 46. Winnier, G., Blessing, M., Labosky, P. A., and Hogan, B. L. M. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9:2105-2116; 1995.
47. 47. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. Mechanism of activation of the TGF-β receptor. Nature 370:341-347; 1994.
48. 48. Yamada, N., Kato, M., ten Dijke, P., Yamashita, H., Sampath, T. K., Heldin, C.-H., Miyazono, K., and Funa, K. Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours. Br J Cancer 73:624-629; 1996.
49. 49. Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., and Matsumoto, K. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270:2008-2011; 1995.
50. 50. Yamashita, H., ten Dijke, P., Franzén, P., Miyazono, K., and Heldin, C.-H. Formation of hetero-oligorneric complexes of type I and type II receptors for transforming growth factor-β. J Biol Chem 269:20172-20178; 1994.
51. 51. Yamashita, H., ten Dijke, P., Huylebroeck, D., Sampath, T. K., andries, M., Smith, J. C., Heldin, C.-H., and Miyazono, K. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol 130:217-226; 1995.
52. 52. Zou, H., and Niswander, L. Requirement for BMP signaling in interdigital apoptosis and scale formation. Science 272:738-741; 1996.